OncoZenge in brief

OncoZenge is a Swedish pharmaceutical company developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge has shown significantly better pain relief compared with today's standard therapy. The company intends to perform a phase 3 development program for regulatory approvals and product launch.